Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Medtronic
McKinsey
Harvard Business School
Mallinckrodt
Queensland Health
Citi
AstraZeneca
Julphar

Generated: November 20, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Pheniramine

« Back to Dashboard

US Patents for Pheniramine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pheniramine ➤ Sign Up Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation Alcon Laboratories, Inc. (Fort Worth, TX) ➤ Sign Up
Pheniramine ➤ Sign Up Process for solubilizing difficulty soluble pharmaceutical actives Richrdson-Vicks Inc. (Shelton, CT) ➤ Sign Up
Pheniramine ➤ Sign Up Method for determining amount of medication in an implantable device Allergan, Inc. (Irvine, CA) ➤ Sign Up
Pheniramine ➤ Sign Up Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same Nitto Denko Corporation (Osaka, JP) ➤ Sign Up
Pheniramine ➤ Sign Up Methods using antiallergics and antihistamines Alcon Laboratories, Inc. (Fort Worth, TX) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Pheniramine

Drugname Country Document Number Estimated Expiration Related US Patent
Pheniramine Australia 2191192 2011-06-27 ➤ Sign Up
Pheniramine Canada 2109623 2011-06-27 ➤ Sign Up
Pheniramine European Patent Office 0591346 2011-06-27 ➤ Sign Up
Pheniramine Ireland 922096 2011-06-27 ➤ Sign Up
Pheniramine Mexico 9203447 2011-06-27 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cantor Fitzgerald
Federal Trade Commission
McKinsey
Mallinckrodt
Fish and Richardson
Daiichi Sankyo
Accenture
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.